Back Pain Doctor
Thoracic Outlet Syndrome
Thoracic outlet syndrome is compression of the structures passing from the neck into the arm, through the gap bounded by the first rib, the collarbone and the scalene muscles. Three different structures can be affected, producing three distinct conditions that share a name. The neurogenic form involves the brachial plexus and makes up roughly 82 to 85 per cent of cases. The venous form causes a swollen, heavy, discoloured arm. The arterial form causes a cold, pale, painful arm. It is uncommon overall - around 2 to 3 new cases per 100,000 people a year - and more frequent in people whose sport or work loads the arms overhead.
Assessment focuses as much on what this is not as on what it is. The conditions that mimic it - cervical radiculopathy, carpal tunnel syndrome, ulnar nerve compression at the elbow, and rotator cuff and other shoulder problems - are all considerably more common and all diagnosable, and working through them properly is the third of the four diagnostic criteria rather than an optional extra. Examination covers the neck, shoulder and the whole upper limb, with attention to hand muscle bulk, tenderness above the collarbone, and whether pressing there reproduces the arm symptoms. A chest x-ray or cervical spine series is recommended in everyone to record whether a cervical rib or elongated C7 transverse process is present. Nerve conduction studies and MRI are used mainly to exclude the alternatives. A swollen or discoloured arm, a cold or pale hand, or a painful blue finger points to the vascular forms and needs urgent assessment; progressive weakness or thinning of the hand muscles needs prompt surgical referral rather than watching.
First-line care where there is no weakness is physiotherapy, ergonomic change and activity modification - typically stretching the tight muscles at the front of the neck and chest, strengthening the muscles that stabilise the shoulder blade, and postural retraining. Injections have a mixed picture: scalene local anaesthetic is used chiefly as a diagnostic aid and forms one of the criteria, while botulinum toxin reduced pain without improving function in the available trial. The honest summary is that there is no multicentre randomised trial of any treatment here, classification has not been uniform across specialties, and decisions rest on clinical judgement rather than strong evidence. Where surgery is being considered it belongs with a vascular, neurosurgical or thoracic surgeon who manages this condition regularly, and given the documented history of unnecessary operations performed for the wrong diagnosis, a second opinion beforehand is reasonable.
Common symptoms
- Arm pain, pins and needles or numbness, often on the little finger side of the hand
- Clearly worse with the arms overhead, or with the arm hanging down
- Tenderness at the base of the neck above the collarbone
- The arm tiring quickly, or in advanced cases thinning of the hand muscles
Commonly seen in
Evidence for twelve treatment options in thoracic outlet syndrome
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation — diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. First line where there is no weakness
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.
What the evidence shows
Conservative treatment is indicated first in the absence of motor signs. Across prospective studies in which patients had standardised physiotherapy and proceeded to surgery only on failure, 27–59% had a satisfactory result (Dengler, Dtsch Arztebl Int 2022). The components — anterior neck and chest stretching, scapular stabiliser strengthening, postural retraining and activity modification — are not standardised between centres, and the literature is vague on specifics.
Pairing reviewed 2026-09-01.
Where it fits for you
The starting point, alongside ergonomic change, where there is no weakness or wasting. Weakness, loss of muscle bulk or hand wasting changes the plan: that goes to a surgical opinion within weeks rather than after a long trial of therapy.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.
What the evidence shows
No trial of trigger point injection in neurogenic thoracic outlet syndrome. Botulinum toxin into the scalenes reduced pain but did not improve function scores, and that is a different intervention.
Where it fits for you
Only where a separate myofascial contributor in the neck or shoulder girdle is identified. It does nothing about compression at the thoracic outlet.
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Mainly diagnostic
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
A properly performed scalene test injection is one of the four Society for Vascular Surgery diagnostic criteria (Illig, J Vasc Surg 2016). As treatment the picture is mixed: botulinum toxin into the anterior and middle scalenes reduced pain without improving DASH or paraesthesia scores, while one randomised crossover trial found corticosteroid injection reduced pain more than scalene stretching (Dengler, Dtsch Arztebl Int 2022).
Where it fits for you
Discussed chiefly for its diagnostic value where the criteria are otherwise borderline. Given the proximity of the brachial plexus and subclavian vessels, this is image-guided work and is best done by, or in concert with, the team who would manage any surgery.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Not used here
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No evidence in this condition, and the supraclavicular fossa contains the brachial plexus and subclavian vessels immediately beneath the skin.
Pairing reviewed 2026-09-01.
Where it fits for you
Not offered for this condition.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Not used here
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
No published trial of shockwave in neurogenic thoracic outlet syndrome. Shockwave is contraindicated over major nerve trunks and large vessels, and the brachial plexus and subclavian artery and vein all lie within the target area.
Where it fits for you
Not offered for this condition, on safety grounds as well as absence of evidence.
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Not used here
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
No published trial, and the same anatomical objection applies with greater force to a focused device, which concentrates energy at depth — the depth at which the plexus and vessels sit.
Pairing reviewed 2026-09-01.
Where it fits for you
Not offered for this condition.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Not used here
What it involves
You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.
What the evidence shows
No published trial of EMTT in neurogenic thoracic outlet syndrome, and no guideline support.
Pairing reviewed 2026-09-01.
Where it fits for you
Not offered for this condition.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Not used here
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No published trial of PRP in neurogenic thoracic outlet syndrome. There is no tendon or joint target here, and injecting around the brachial plexus is not a described indication.
Pairing reviewed 2026-09-06.
Where it fits for you
Not offered for this condition.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Not used here
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No established role in neurogenic thoracic outlet syndrome.
Pairing reviewed 2026-09-06.
Where it fits for you
Not offered for this condition.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used here
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
No role in nerve entrapment.
Where it fits for you
Not offered for this problem.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Not used here
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Perineural injection targets irritated superficial cutaneous nerve branches. The problem in this condition is compression of a nerve plexus at the thoracic outlet, which is not that target.
Where it fits for you
Not offered for this condition.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Not used here
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
No published trial of brachial plexus hydrodissection in neurogenic thoracic outlet syndrome. The randomised hydrodissection evidence is in carpal tunnel syndrome and does not transfer to a plexus lying alongside the subclavian artery and vein.
Where it fits for you
Not offered for this condition. Symptoms that persist after a fair trial of physiotherapy go to a vascular, neurosurgical or thoracic surgical opinion rather than to a further injectate.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.
When we would still consider it
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal — a trip, a procedure, a return to work
- Diagnostic use, where the response tells us where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other neck conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
Is there a test that proves I have it?
What are the criteria?
Will I need surgery?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
Book an appointment